These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 647347)

  • 1. Sulphinpyrazone after myocardial infarction.
    Kane SH
    Br Med J; 1978 Jun; 1(6125):1484. PubMed ID: 647347
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial re-infarction and sulphinpyrazone.
    Watt M
    N Z Med J; 1978 Sep; 88(619):213. PubMed ID: 280805
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction.
    Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A
    Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
    Wilcox RG; Richardson D; Hampton JR; Mitchell JR; Banks DC
    Br Med J; 1980 Aug; 281(6239):531-4. PubMed ID: 7000264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction with sulphinpyrazone therapy.
    Boelaert J; Van Eeghem P; Fagard R; Lijnen P; Daneels R; Schurgers M; Verschueren LJ; Amery A
    Am Heart J; 1982 Jul; 104(1):174-5. PubMed ID: 7090980
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulphinpyrazone in acute myocardial infarction.
    Lijnen P; Verschueren LJ; Amery A; Boelaert J; Daneels R; Schurgers M; Van Eeghem P
    Br Med J; 1980 Oct; 281(6246):1005. PubMed ID: 7427530
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute renal failure secondary to sulfinpyrazone treatment after myocardial infarction.
    Docci D; Mambelli M; Manzoni G; Turci F; Salvi G
    Nephron; 1984; 37(3):213-4. PubMed ID: 6738772
    [No Abstract]   [Full Text] [Related]  

  • 8. Non oliguric acute renal failure after treatment with sulfinpyrazone.
    Keidar S; Kohan R; Levy J; Grenadier E; Palant A; Ben Ari J
    Clin Nephrol; 1982 May; 17(5):266-7. PubMed ID: 7094443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction.
    S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute renal dysfunction due to sulfinpyrazone therapy in post-myocardial infarction cardiomegaly: reversible hypersensitive interstitial nephritis.
    Howard T; Hoy RH; Warren S; Georgiev M; Selinger H
    Am Heart J; 1981 Aug; 102(2):294-5. PubMed ID: 7258104
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphinpyrazone (Anturan) after myocardial infarction.
    Nicholson MR; Whitlock RM
    N Z Med J; 1979 Sep; 90(644):263. PubMed ID: 390442
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulphinpyrazone and warfarin after myocardial infarction.
    Domenet J
    Br Med J; 1979 Aug; 2(6188):497. PubMed ID: 487024
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulphinpyrazone after myocardial infarction.
    Weston MJ
    Lancet; 1978 Apr; 1(8067):766-7. PubMed ID: 76764
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial re-infarction and sulphinpyrazone.
    N Z Med J; 1978 Aug; 88(617):106. PubMed ID: 362256
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute renal failure following sulfinpyrazone therapy.
    Scherrer JJ; Jackson JW; Jerde OM
    S D J Med; 1982 Apr; 35(4):17-9. PubMed ID: 6954641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute renal failure induced by sulfinpyrazone (author's transl)].
    Boelaert J; Meyrier A; Sraer JD; Morel-Maroger L; Kourilsky O; Dard S; El Nahas M; Van Eeghem P; Daneels R
    Nephrologie; 1981; 2(3):92-5. PubMed ID: 7301034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
    Kubik MM; Richardson SG
    Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphinpyrazone and renal function following myocardial infarction.
    Choudhury SL; Taylor SH; Wieringa G; Swaminathan R; Morgan DB
    Eur J Clin Pharmacol; 1983; 24(6):747-50. PubMed ID: 6884411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of mortality by sulphinpyrazone after experimental myocardial infarction in the rat.
    Brunner L; Stepanek J; Brunner H
    J Pharm Pharmacol; 1980 Oct; 32(10):714-5. PubMed ID: 6107349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.